FOLH1 and metastatic neoplasm: Our results suggest that use of PSMA-PET alone or as a reflex test following negative findings with conventional imaging is expected to detect more than twice the number of patients with metastatic disease and lead to the initiation of systemic therapy in more than 60% of patients imaged.